antiemetic agents as they show a potent dopamine D2 and
5-HT3 receptors inhibitory activity.6 These heterocycles
have also been employed as ligands for transition metal ion
coordination7 and used as bleach catalysts or to support
cationic group 3 metal alkyl catalysts.8 Moreover, the
gadolinium(III)-complex of the tetraacetic acid derivative
of 6-methyl-6-amino-1,4-perhydrodiazepine (AAZTA)
was reported as an efficient contrast agent for magnetic
resonance imaging.9 The insertion of various groups at the
6-position would differentiate the biological activity of this
versatile heterocycle and would also permit the synthesis of
AAZTA derivatives containing various functional groups
useful for bioconjugation and relevant for the future
development of efficient molecular imaging probes.10
In parallel, there is great current interest in the develop-
ment of new tandem and multicomponent domino reac-
tions in order to introduce not only high molecular
complexity and diversity but also matched functionalities
suitable for further transformations or for the conjuga-
tion to biomolecules. Actually, the combination of such
reactions with an efficient post-transformation, typically
a ring-forming process, has proved to be a powerful tool
for the synthesis of highly functionalized heterocyclic
compounds.11
can be applied to β-nitro alcohols14 and, as shown by
Harada et al.,15 to 6-hydroxymethyl-6-nitroperhydrodia-
zepines in order to replace the hydroxymethyl group with a
hydrogen atom. The stable carbanion/nitronate 2(Scheme 1)
was formed in a few minutes by reaction of 1 with a slight
excess of t-BuOK in THF. Owing to the resonance stabi-
lization, 2 can be isolated and characterized by spectro-
scopic techniques (see the Supporting Information for
details). In particular, the 13C NMR spectrum in CD3OD
clearly shows that 2 exists as a nitronate with the CdN
carbon resonating at 121.7 ppm. This was also confirmed
by IR spectroscopy, which shows a strong peak at 1597 cmꢀ1
assigned to the CdN stretching of the nitronate, whereas
the tertiary aliphatic nitro group in 1 is observed at around
1535 cmꢀ1
.
Scheme 1. Formation of the Carbanion/Nitronate Intermediate
We have recently reported the fast and easy synthesis of
1,4-dibenzyl-6-hydroxymethyl-6-nitroperhydro-1,4-diaze-
pine (1) by double nitro-Mannich reaction between N,N0-
dibenzylethylenediamine, paraformaldehyde, and 2-nitro-
ethanol in nearly quantitative yield.12 Herein we account
for the preparation of a series of derivatives obtained from
1 via novel cascade sequences initiated by a retro-Henry
reaction followed by either a Michael or a Mannich reac-
tion. The versatility of these approaches was tested with
several acrylic derivatives and with different primary and
secondary amines.
We thought to use such a species as a nucleophile with
the aim to further functionalize the heterocycle ring and
to obtain precursors of 6-aminoperhydro-1,4-diazepines
variously substituted at the 6-position. First, simple halo
and pseudohalo compounds (e.g., short aliphatic chlorides
and bromides, mesylates, tosylates) were used as substrates
for common substitution reactions. However, no forma-
tion of the desired products or any other byproduct was
observed. The attempts of using carbonyl or carboxyl
derivatives (including acetone, acetonitrile, ethyl acetate)
for carbonyl addition reactions were also unsuccessful.
Instead, a Michael addition followed the retro-Henry
reaction when two molar equivalents of an acrylic com-
pound were added along with t-BuOK in THF. The
corresponding products were formed within a few hours
in good yields and relatively pure. The results obtained
with several commercial acrylic compounds as well as acrylic
derivatives synthesized ad hoc are reported in Table 1
(see the Supporting Information for details).
The retro-Henry reaction is well-known although rarely
employed in organic synthesis;13 it normally involves a
base-mediated process to obtain, in first instance, a carbo-
nyl compound and a stabilized carbanion. This reaction
(6) (a) Hirokawa, Y.; Horikawa, T.; Noguchi, H.; Yamamoto, K.;
Kato, S. Org. Process Res. Dev. 2002, 6, 28. (b) Hirokawa, Y.; Fujiwara,
I.; Suzuki, K.; Harada, H.; Yoshikawa, T.; Noguchi, H.; Kato, S.
J. Med. Chem. 2003, 46, 702. (c) Hirokawa, Y.; Harada, H.; Yoshikawa,
T.; Noguchi, H.; Kato, S. Chem. Pharm. Bull. 2002, 50, 941.
(7) (a) Romba, J.; Kuppert, D.; Morgenstern, B.; Neiz, C.; Steinhauser,
S.; Weyhermuller, T.; Hegetschweiler, K. Eur. J. Inorg. Chem. 2006, 314.
(b) Peralta, R. A.; Neves, A.; Bortoluzzi, A. J.; Casellato, A.; Dos Anjos,
A.; Greatti, A.; Xavier, F. R.; Szpoganicz, B. Inorg. Chem. 2005, 44,
7690.
(8) (a) Ge, S.; Bambirra, S.; Meetsma, A.; Hessen, B. Chem. Commun.
2006, 3320. (b) Ge, S.; Bambirra, S.; Meetsma, A.; Hessen, B. Organo-
metallics 2007, 26, 5278.
(9) (a) Aime, S.; Calabi, L.; Cavallotti, C.; Gianolio, E.; Giovenzana,
G. B.; Losi, P.; Maiocchi, A.; Palmisano, G.; Sisti, M. Inorg. Chem. 2004,
43, 7588. (b) Gugliotta, G.; Botta, M.; Tei, L. Org. Biomol. Chem. 2010,
8, 4569.
Adamantyl derivatives 6 and 9 were synthesized with
the aim at preparing molecules able to form inclusion
compounds with β-cyclodextrin with high affinity and
selectivity.16 The other compounds have been prepared
in order to get a series of 6-nitro-1,4-diazepines substituted
at the 6-position with protected or pseudoprotected func-
tional groups.
(10) Lattuada, L.; Barge, A.; Cravotto, G.; Giovenzana, G. B.; Tei,
L. Chem Soc. Rev. 2011, 40, 3019.
(11) (a) Padwa, A. Pure Appl. Chem. 2004, 76, 1933. (b) Domino
Reactions in Organic synthesis; Tietze, L. F., Brasche, G., Gericke, K. M.,
Eds.; Wiley-VCH: Weinheim, 2006. (c) Padwa, A.; Bur, S. K. Tetrahedron
2007, 63, 5341.
~
~
(14) (a) Camps, P.; Munoz-Torrero, D.; Munoz-Torrero, V. Tetra-
hedron 1995, 51, 6587. (b) Tanaka, S.; Oguma, Y.; Tanaka, Y.; Echizen,
H.; Masu, H.; Yamaguchi, K.; Kishikawa, K.; Kohmoto, S.; Yamamoto,
M. Synth. Commun. 2009, 39, 868.
(15) Harada, H.; Hirokawa, Y.; Morie, T.; Kato, S. Heterocycles
1995, 41, 363.
(16) Jaime, C.; Redondo, J.; Sanchez-Ferrando, F.; Virgili, A. J. Mol.
(12) Gugliotta, G.; Botta, M.; Giovenzana, G. B.; Tei, L. Bioorg.
Med. Chem. Lett. 2009, 19, 3442–3444.
ꢀ
(13) Luzzio, F. A. Tetrahedron 2001, 57, 915.
Struct. 1991, 248, 317.
Org. Lett., Vol. 14, No. 3, 2012
717